By Ashley Sadler
A safety panel of the European Union’s drug watchdog organization recommended Friday that “heavy menstrual bleeding” be listed as a side effect of Pfizer and Moderna’s mRNA COVID-19 jabs. The advice comes after reports of menstrual irregularities connected to the shots were widely dismissed as “misinformation.”
The European Medicines Agency (EMA) published the recommendation on Friday in its highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) panel’s meetings spanning October 24-27.
According to the EMA, the PRAC panel recommended that “heavy menstrual bleeding should be added to the product information as a side effect of unknown frequency of the mRNA COVID-19 vaccines Comirnaty [Pfizer-BioNTech] and Spikevax [Moderna].”
Most cases reviewed were non-serious and temporary.
Read the highlights: https://t.co/2HUM9nAU6I
— EU Medicines Agency (@EMA_News) October 28, 2022
“Heavy menstrual bleeding (heavy periods) may be defined as bleeding characterised by an increased volume and/or duration which interferes with the person’s physical, social, emotional and material quality of life,” the statement continued. “Cases of heavy menstrual bleeding have been reported after the first, second and booster doses of Comirnaty and Spikevax.”
The recommendation comes after the PRAC reportedly reviewed existing data from clinical trials and cases reported to Eudravigilance (The EMA’s adverse event reporting system), as well as “findings from the medical literature.” In consequence, the PRAC found that heavy menstrual bleeding is a “reasonable possibility” that is “causally associated” with the injections, but said the occurrence is generally “non-serious and temporary in nature.”
The recommendation that heavy menstrual bleeding be officially added as a potential side effect for commonly given COVID-19 shots comes after claims regarding menstrual irregularities were initially disregarded as “misinformation.”
“So far, there’s no data linking the vaccines to changes in menstruation,” Alice Lu-Culligan and Dr Randi Hutter Epstein at Yale School of Medicine wrote in the New York Times last year. “Even if there is a connection, one unusual period is no cause for alarm.”
Meanwhile, despite the recent acknowledgement by the EU drug watchdog organization that the COVID jabs can indeed cause menstrual irregularities, the PRAC went on in its statement to attempt to quell fears that the COVID shots would “have any impact on reproduction and fertility.”
“Available data provides reassurance about the use of mRNA COVID-19 vaccines before and during pregnancy,” the statement read, using gender-neutral language as it explained that, according to a review by the EMA’s Emergency Task Force, “mRNA COVID-19 vaccines do not cause pregnancy complications for expectant mothers and their babies, and they are as effective at reducing the risk of hospitalisation and deaths in pregnant people as they are in non-pregnant people.”
However, not all experts agree that the jabs are safe for pregnant or breastfeeding women.
Earlier this month, OB/GYN Dr. James Thorp said he has seen a “massive” increase in miscarriages and fetal abnormalities since the rollout of the COVID jabs.
As LifeSiteNews reported, Thorp said he has seen increases in fetal malformation, fetal cardiac abnormalities, fetal cardiac arrhythmias, fetal cardiac arrest, and severe placental problems causing inter-uterine growth restrictions, and even vaccine-acquired immunodeficiency syndrome (VAIDS).
“It’s way off the charts,” he said.
Likewise, during a “Stop the Shot” conference streamed last year by LifeSiteNews, maternal-fetal medicine specialist Dr. Richard Blumrick explained that the mRNA-developed jabs may be able to cross the placental barrier, putting vaccine recipients at risk of fertility complications.
In addition, commenting on the effects of the experimental jabs, Dr. Roger Hodkinson, CEO of Western Medical Assessments, argued that continuing to roll out the shots for pregnant women is “stark raving mad.”
“I’m blisteringly annoyed about the risks that we are subjecting pregnant women to, and younger women who might wish to become pregnant in the future, and their husbands,” he said.
To date, there have been 5,112 miscarriages and 148 stillbirths reported to the U.S. Vaccine Adverse Event Reporting System (VAERS) from the rollout of the shots through October 21, 2022.
Meanwhile, a study published in September by the Journal of the American Medical Association (JAMA) Pediatrics found “trace amounts of COVID-19 vaccine mRNA” in the breast milk of almost half of the women studied. The results of the research prompted the medical group to urge “caution” in breastfeeding infants six months or younger “in the first two days after maternal COVID-19 vaccination.”
However, the PRAC said in its Friday statement that, according to existing research, “the totality of data available confirms that the benefits of these vaccines greatly outweigh the risks.”
Earlier this month, the EMA officially recommended that European babies as young as six months old get jabbed with the experimental shots in spite of evidence that children’s risk from COVID has long been exaggerated.